[Top][All Lists]
[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
[Gnumed-devel] Should EMRs warn about drug warnings and recalls?
From: |
Jim Busser |
Subject: |
[Gnumed-devel] Should EMRs warn about drug warnings and recalls? |
Date: |
Sat, 03 Sep 2011 14:47:10 -0700 |
I have not used an EMR sufficiently to have experienced alerts fatigue.
Some of this may be nicely handled by extrnal tools such as FreeDIams. Even so,
at minimum, if a drug has been taken off the market on account of being
dangerous (if not illegal) it may be advisable for the EMR itself to assist to
(a) issue no new prescriptions and
(b) avise patients to stop taking it
Such notices and warnings could occur at the level of the "brand" or at the
level of the "substance".
When the focus of a recall is restricted to the brand-level (not affecting
other supplies), something would be wrong with their quality control or
sabotage etc.
Substance-wise warnings will arise from issues with
- the substance "inherently" or
- some function of dosage (DDD) or drug or disease interactions
Therefore is there any useful concept of storing within GNUmed a substance and
a Brand
availability / status / flag
where the default is null (normal) and possible alternate values could include:
withdrawn
caution
restricted
which reminds me that I wondered whether the concept "is_approved_of" should
live only in substance_intake or whether it makes sense to have a default in
consumable_substance
which can be overridden at the patient level?
-- Jim
- [Gnumed-devel] Should EMRs warn about drug warnings and recalls?,
Jim Busser <=